Gauthier S - Search Results

1

Alzheimer's disease: the pharmacological pathway.

Allain H, Bentué-Ferrer D, Tribut O, Gauthier S, Michel BF, Drieu-La Rochelle C. Allain H, et al. Among authors: gauthier s. Fundam Clin Pharmacol. 2003 Aug;17(4):419-28. doi: 10.1046/j.1472-8206.2003.00153.x. Fundam Clin Pharmacol. 2003. PMID: 12914543 Review.

2

Synthesis and comparison of the meta-analyses evaluating the efficacy of memantine in moderate to severe stages of Alzheimer's disease.

Rive B, Gauthier S, Costello S, Marre C, François C. Rive B, et al. Among authors: gauthier s. CNS Drugs. 2013 Jul;27(7):573-82. doi: 10.1007/s40263-013-0074-x. CNS Drugs. 2013. PMID: 23765561 Free PMC article. Review.

3

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.

Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Gauthier S, et al. Curr Med Res Opin. 2003;19(8):707-14. doi: 10.1185/030079903125002450. Curr Med Res Opin. 2003. PMID: 14687441 Review.

4

Alzhemed: a potential treatment for Alzheimer's disease.

Aisen PS, Gauthier S, Vellas B, Briand R, Saumier D, Laurin J, Garceau D. Aisen PS, et al. Among authors: gauthier s. Curr Alzheimer Res. 2007 Sep;4(4):473-8. doi: 10.2174/156720507781788882. Curr Alzheimer Res. 2007. PMID: 17908052 Review.

5

Alzheimer disease: clinical use of cholinergic drugs in Alzheimer disease.

Desmarais JE, Gauthier S. Desmarais JE, et al. Among authors: gauthier s. Nat Rev Neurol. 2010 Aug;6(8):418-20. doi: 10.1038/nrneurol.2010.105. Nat Rev Neurol. 2010. PMID: 20689561

6

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria.

Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, Delacourte A, Galasko D, Gauthier S, Jicha G, Meguro K, O'brien J, Pasquier F, Robert P, Rossor M, Salloway S, Stern Y, Visser PJ, Scheltens P. Dubois B, et al. Among authors: gauthier s. Lancet Neurol. 2007 Aug;6(8):734-46. doi: 10.1016/S1474-4422(07)70178-3. Lancet Neurol. 2007. PMID: 17616482 Review.

7

Alzheimer's disease: the benefits of early treatment.

Gauthier SG. Gauthier SG. Eur J Neurol. 2005 Oct;12 Suppl 3:11-6. doi: 10.1111/j.1468-1331.2005.01322.x. Eur J Neurol. 2005. PMID: 16144532 Review.

8

Galantamine demonstrates efficacy and safety in elderly patients with Alzheimer disease.

Marcusson J, Bullock R, Gauthier S, Kurz A, Schwalen S. Marcusson J, et al. Among authors: gauthier s. Alzheimer Dis Assoc Disord. 2003 Jul-Sep;17 Suppl 3:S86-91. doi: 10.1097/00002093-200307003-00005. Alzheimer Dis Assoc Disord. 2003. PMID: 14512822

9

Update on the pharmacological treatment of Alzheimer's disease.

Massoud F, Gauthier S. Massoud F, et al. Among authors: gauthier s. Curr Neuropharmacol. 2010 Mar;8(1):69-80. doi: 10.2174/157015910790909520. Curr Neuropharmacol. 2010. PMID: 20808547 Free PMC article.

10

Treatment success in Alzheimer's disease.

Gauthier S. Gauthier S. J Nutr Health Aging. 2006 Sep-Oct;10(5):416. J Nutr Health Aging. 2006. PMID: 17066214 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,127 results

Search Page

Filters